Patent ID: 7550261

Claim:
A method of identifying a male Caucasian human subject at increased risk of experiencing a hypersensitivity reaction to a therapeutic regime of abacavir, comprising: (a) performing a genotyping technique on a biological sample from said subject to determine whether the subject's HLA-B genotype includes an allele selected from the HLA-B57 allele and the HLA-B*5701 allele; (b) detecting an HLA-B57 allele or an HLA-B*5701 allele; and (c) correlating the detection of an HLA-B57 or an HLA-B*5701 allele with an increased risk of experiencing a hypersensitivity reaction to a therapeutic regime of abacavir compared to the risk if no HLA-B57 or HLA-B*5701 allele were detected.